Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type II Diabetes
Interventions
DRUG

Farxiga

Farxiga 10mg/day

DRUG

Placebo

Placebo

DRUG

Metformin

Metformin background therapy \>/= 1500mg/day

DRUG

Insulin

Insulin \>/= 30 units

Trial Locations (26)

Unknown

Research Site, Birmingham

Research Site, Phoenix

Research Site, Huntington Park

Research Site, Los Angeles

Research Site, Sacramento

Research Site, San Diego

Research Site, West Hills

Research Site, Cooper City

Research Site, Miami

Research Site, Evanston

Research Site, Oxon Hill

Research Site, Henderson

Research Site, Brooklyn

Research Site, Rochester

Research Site, Greensboro

Research Site, Cincinnati

Research Site, Dublin

Research Site, Franklin

Research Site, Eugene

Research Site, Lansdale

Research Site, Spartanburg

Research Site, Bartlett

Research Site, Dallas

Research Site, Houston

Research Site, Hurst

Research Site, Renton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY